{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:09:43Z","timestamp":1791263383654,"version":"4.1.0"},"reference-count":20,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Endocrine glands-derived-vascular endothelial growth factor (EG-VEGF) was recently cloned as a new angiogenic factor that selectively acts on the endothelium of endocrine gland cells. We evaluated the involvement of EG-VEGF in colorectal cancer. The expression of EG-VEGF was confirmed in all of the colorectal cancer cell lines. (On the other hand, the expression of EG-VEGF mRNA was not detected in colorectal normal mucosae.) Stable EG-VEGF infectors of colorectal cancer cell line SW620 were produced, EG-VEGF transfectants were implanted into cecum and s.c., and cell proliferation was evaluated. Angiogenesis was evaluated by dorsal air sac method. Liver metastasis was evaluated after the implantation of EG-VEGF transfectants into the mouse spleen. Tumor proliferation (cecum, s.c.) was significantly higher in the EG-VEGF transfectants than in the control cells. The small vessels were significantly increased in EG-VEGF transfectants as compared with those in control cells. Also, liver metastatic ratio was higher in the EG-VEGF transfectants than in the control cells. In this study, EG-VEGF, a new angiogenic factor, may lead to angiogenesis, promoting cell proliferation and liver metastasis in colorectal cancers. When the EG-VEGF gene-overexpressing colorectal cancer cell line that had been treated with phosphorothioate antisense EG-VEGF oligonucleotides was injected s.c. into mice, angiogenesis and tumor growth were inhibited. Although the novel angiogenesis factor EG-VEGF was not expressed in the normal colorectal mucosa, it was expressed in colorectal cancer cells, which indicates that it is a cancer-specific and possibly tissue-specific angiogenesis factor in the large intestine, and which suggests that it can be targeted by a novel antiangiogenesis therapy.<\/jats:p>","DOI":"10.1158\/0008-5472.can-3696-2","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T22:37:44Z","timestamp":1127255864000},"page":"1906-1910","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Angiogenesis and Tumor Proliferation\/Metastasis of Human Colorectal Cancer Cell Line SW620 Transfected with Endocrine Glands-Derived-Vascular Endothelial Growth Factor, As a New Angiogenic Factor"],"prefix":"10.1158","volume":"64","author":[{"given":"Takanori","family":"Goi","sequence":"first","affiliation":[{"name":"Department of Surgery I, Fukui Medical University, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Fukui Medical University, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Satoh","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Fukui Medical University, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Tabata","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Fukui Medical University, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Koneri","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Fukui Medical University, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nagano","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Fukui Medical University, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Hirono","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Fukui Medical University, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Fukui Medical University, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Fukui Medical University, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Fukui Medical University, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2004,3,16]]},"reference":[{"key":"2022061620131273400_B1","doi-asserted-by":"crossref","unstructured":"Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79:\u2008185-8, \u20081994.","DOI":"10.1016\/0092-8674(94)90187-2"},{"key":"2022061620131273400_B2","doi-asserted-by":"crossref","unstructured":"Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86:\u2008353-64, \u20081996.","DOI":"10.1016\/S0092-8674(00)80108-7"},{"key":"2022061620131273400_B3","unstructured":"Hong YK, Chung DS, Joe YA, et al Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-\u03b2 treatment at early stage of tumor development. Clin. Cancer Res, 6:\u20083354-60, \u20082000."},{"key":"2022061620131273400_B4","unstructured":"Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T. HGF\/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res, 60:\u20086737-43, \u20082000."},{"key":"2022061620131273400_B5","unstructured":"Rofstad EK, Halsor EF. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res, 60:\u20084932-8, \u20082000."},{"key":"2022061620131273400_B6","doi-asserted-by":"crossref","unstructured":"Bussolino F, Di Renzo MF, Ziche M, et al Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol, 119:\u2008629-41, \u20081992.","DOI":"10.1083\/jcb.119.3.629"},{"key":"2022061620131273400_B7","doi-asserted-by":"crossref","unstructured":"Risau W. Mechanisms of angiogenesis. Nature (Lond.), 386:\u2008671-4, \u20081997.","DOI":"10.1038\/386671a0"},{"key":"2022061620131273400_B8","doi-asserted-by":"crossref","unstructured":"Hotz HG, Reber HA, Hotz B, et al Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth. J Gastrointest Surg, 5:\u2008131-18, \u20082001.","DOI":"10.1016\/S1091-255X(01)80024-X"},{"key":"2022061620131273400_B9","unstructured":"Beliveau R, Gingras D, Kruger EA, et al The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects. Clin Cancer Res, 8:\u20081242-50, \u20082002."},{"key":"2022061620131273400_B10","unstructured":"Laird AD, Vajkoczy P, Shawver LK, et al SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res, 60:\u20084152-60, \u20082000."},{"key":"2022061620131273400_B11","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly MS, Boehm T, Shing Y, et al Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88:\u2008277-85, \u20081997.","DOI":"10.1016\/S0092-8674(00)81848-6"},{"key":"2022061620131273400_B12","doi-asserted-by":"crossref","unstructured":"LeCouter J, Kowalski J, Foster J, et al Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature (Lond.), 412:\u2008877-84, \u20082001.","DOI":"10.1038\/35091000"},{"key":"2022061620131273400_B13","doi-asserted-by":"crossref","unstructured":"Arai N, Strom A, Rafter JJ, Gustafsson JA. Estrogen receptor \u03b2 mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biophys Res Commun, 270:\u2008425-31, \u20082000.","DOI":"10.1006\/bbrc.2000.2444"},{"key":"2022061620131273400_B14","doi-asserted-by":"crossref","unstructured":"Goi T, Shipitsin M, Lu Z, Foster DA, Klinz SG, Feig LA. An EGF receptor\/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity. EMBO J, 19:\u2008623-30, \u20082000.","DOI":"10.1093\/emboj\/19.4.623"},{"key":"2022061620131273400_B15","doi-asserted-by":"crossref","unstructured":"Kuruppu D, Christophi C, Bertram JF, O\u2019Brien PE. Tamoxifen inhibits colorectal cancer metastases in the liver: a study in a murine model. J Gastroenterol Hepatol, 13:\u2008521-7, \u20081998.","DOI":"10.1111\/j.1440-1746.1998.tb00680.x"},{"key":"2022061620131273400_B16","doi-asserted-by":"crossref","unstructured":"Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med, 285:\u20081182-6, \u20081971.","DOI":"10.1056\/NEJM197111182852108"},{"key":"2022061620131273400_B17","doi-asserted-by":"crossref","unstructured":"Kim KJ, Li B, Winer J, et al Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362:\u2008841-4, \u20081993.","DOI":"10.1038\/362841a0"},{"key":"2022061620131273400_B18","doi-asserted-by":"crossref","unstructured":"Folkman J. Clinical applications of research on angiogenesis. N Engl J Med, 333:\u20081757-63, \u20081995.","DOI":"10.1056\/NEJM199512283332608"},{"key":"2022061620131273400_B19","doi-asserted-by":"crossref","unstructured":"Kudelka AP, Verschraegen CF, Loyer E. Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470. N Engl J Med, 338:\u2008991-2, \u20081998.","DOI":"10.1056\/NEJM199804023381412"},{"key":"2022061620131273400_B20","unstructured":"Fong TA, Shawver LK, Sun L, et al SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1\/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res, 59:\u200899-106, \u20081999."}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/6\/1906\/2523429\/zch00604001906.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/6\/1906\/2523429\/zch00604001906.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T20:57:31Z","timestamp":1655413051000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/64\/6\/1906\/512315\/Angiogenesis-and-Tumor-Proliferation-Metastasis-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,15]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,3,16]]},"published-print":{"date-parts":[[2004,3,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-3696-2","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,15]]}}}